National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1304049

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 7/9/2021

VAERS ID: 1304049
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-01-26
Onset:2021-02-04
Submitted:0000-00-00
Entered:2021-05-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6134 / 1 - / -

Administered by: Other      Purchased by: ??
Symptoms: Cerebral haemorrhage, Encephalitis, Epilepsy, Meningitis, Seizure

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-04-11
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: CLOPIDOGREL; CITALOPRAM; XARELTO
Current Illness: Chronic obstructive airways disease; Overweight; Smoker; Wheelchair user
Preexisting Conditions: Medical History/Concurrent Conditions: Cerebral thrombosis
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': DKPFIZER INC2021496680

Write-up: meningitis; encephalitis; seizures; epileptic seizures; cerebral hemorrhage with consequences that resulted in death; This is a spontaneous report received from a contactable consumer downloaded from the Regulatory Authority. A 73-years-old female patient received BNT162B2 (COMIRNATY), dose 1, via an unspecified route of administration on 26Jan2021 (Batch/Lot Number: EJ6134; Expiration Date: 30Apr2021) as SINGLE DOSE for covid-19 immunisation. Medical history included ongoing wheelchair user, ongoing Smoker, cerebral thrombosis from 2006 to an unknown date, ongoing Chronic obstructive airways disease, ongoing overweight. Concomitant medication(s) included clopidogrel taken for thrombosis prophylaxis from 13Oct2015; citalopram taken for depression from 01Jan2008; rivaroxaban (XARELTO) taken for thrombosis prophylaxis from 17Sep2015. The patient experienced cerebral hemorrhage with consequences that resulted in death (death, hospitalization) on 04Feb2021. As a consequence of Cerebral hemorrhage the patient experienced meningitis, encephalitis and after 2 months of treatment increasing seizures and epileptic seizures. The patient is operated and gets a bleeding again the next day with and is operated a second time. Treatment was discontinued and the patient dies on 11Apr2021. An autopsy was not performed. There is no information regarding test results. The outcome of the events was Fatal. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: meningitis; encephalitis; seizures; epileptic seizures; Cerebral hemorrhage

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1304049&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166